美国 · 平台与数据 · TheStreet
Moderna stock’s 17% slump was a ‘sell the news’ event, analyst says
Moderna shares tumbled after leaked cancer vaccine trial data showed promising results for its treatment developed with Merck.
在 TheStreet 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.thestreet.com)
